Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.
D000328:Adult; D000368:Aged; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011863:Radioimmunoassay; D011956:Receptors, Cell Surface; D012636:Secretory Rate; D013268:Stimulation, Chemical; D013997:Time Factors
D011956:Receptors, Cell Surface; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D013006:Growth Hormone